Mert Erciyestepe

6PUBLICATIONS
66CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsMedical mycology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jun 25, 2026
Efficacy and tolerability of CDK 4/6 inhibitors in HR-positive HER2-negative de novo metastatic breast cancer patients aged ≥ 70 years.

|Apr 27, 2026
Perioperative FLOT versus Definitive 50.4 Gy Chemoradiotherapy in Siewert II Esophagogastric Junction Adenocarcinoma: A Multicenter Retrospective Cohort Study.

|Mar 23, 2026
Real-world effectiveness of total neoadjuvant therapy in locally advanced rectal cancer: a multicenter retrospective study.

Osman Sütcüoğlu, Orhun Akdoğan, İlknur Deliktaş Onur

|Aug 27, 2025
Bevacizumab Efficacy and Tolerability in Patients with Metastatic Platinum-Sensitive Ovarian Cancer Beyond Progression.

Mert Erciyestepe, Şermin Dinç Sonuşen, Şaban Seçmeler

|Jan 14, 2025
Evaluation of ixabepilone efficacy and tolerability in metastatic breast cancer.

Mert Erciyestepe, Ömer Burak Ekinci, Şaban Seçmeler

|Aug 01, 2020
A Case with Hepatic Involvement Mimicking Metastatic Disease in Multiple Myeloma.

Mert Erciyestepe, Tarık Onur Tiryaki, İpek Yönal Hindilerden

Pageof 1

Frequent Collaborators

2 joint publications

Şermin Dinç Sonuşen

2 joint publications

Okan Aydın

2 joint publications

Emir Çelik

2 joint publications

Kayhan Erturk